Artwork

Contenu fourni par Dr. Francavilla. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par Dr. Francavilla ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.
Player FM - Application Podcast
Mettez-vous hors ligne avec l'application Player FM !

Beyond Ozempic: The Future of Obesity Medicine with Dr. Mike Albert

36:03
 
Partager
 

Manage episode 445173493 series 3415408
Contenu fourni par Dr. Francavilla. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par Dr. Francavilla ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.

Check out the Medical Weight Loss Summit, launching on October 15th, 2024, which I collaborated on with Dr. Talks!

Link: Medical Weight Loss Summit — Dr. Francavilla Show

What’s changing in the field of obesity medicine?

Keeping up with the changes in obesity medicine can be a bit tricky, which is why Dr. Mike Albert, a board-certified specialist in internal and obesity medicine and co-founder of Accomplish Health, is here to share his insights. Accomplish Health is a telehealth practice focused on providing comprehensive obesity care. When he's not working, Dr. Albert educates over 300,000 followers on social media about all things obesity.

In this episode, Dr. Albert dives into the latest advancements in obesity care, especially the rise of GLP-1 medications. These new treatments are shaking things up and offering more effective options, but with big companies getting involved, there’s concern about whether quality care is getting lost in the rush for profit. He points out that these hormone-based therapies use hormones from the gastrointestinal tract to help regulate appetite and energy, and they’re actually more potent than the hormones our bodies naturally produce — all thanks to some cool advances in biotechnology.

The discussion also covers how we’re shifting our view of obesity from just focusing on weight loss to recognizing it as a complex chronic disease with metabolic implications. It’s a big change that highlights the need for a more comprehensive approach to treatment.

If you’re curious about the latest trends and insights in obesity medicine, be sure to tune in to the latest episode.

Check out Calocurb:

Connect with me:

  continue reading

115 episodes

Artwork
iconPartager
 
Manage episode 445173493 series 3415408
Contenu fourni par Dr. Francavilla. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par Dr. Francavilla ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.

Check out the Medical Weight Loss Summit, launching on October 15th, 2024, which I collaborated on with Dr. Talks!

Link: Medical Weight Loss Summit — Dr. Francavilla Show

What’s changing in the field of obesity medicine?

Keeping up with the changes in obesity medicine can be a bit tricky, which is why Dr. Mike Albert, a board-certified specialist in internal and obesity medicine and co-founder of Accomplish Health, is here to share his insights. Accomplish Health is a telehealth practice focused on providing comprehensive obesity care. When he's not working, Dr. Albert educates over 300,000 followers on social media about all things obesity.

In this episode, Dr. Albert dives into the latest advancements in obesity care, especially the rise of GLP-1 medications. These new treatments are shaking things up and offering more effective options, but with big companies getting involved, there’s concern about whether quality care is getting lost in the rush for profit. He points out that these hormone-based therapies use hormones from the gastrointestinal tract to help regulate appetite and energy, and they’re actually more potent than the hormones our bodies naturally produce — all thanks to some cool advances in biotechnology.

The discussion also covers how we’re shifting our view of obesity from just focusing on weight loss to recognizing it as a complex chronic disease with metabolic implications. It’s a big change that highlights the need for a more comprehensive approach to treatment.

If you’re curious about the latest trends and insights in obesity medicine, be sure to tune in to the latest episode.

Check out Calocurb:

Connect with me:

  continue reading

115 episodes

모든 에피소드

×
 
Loading …

Bienvenue sur Lecteur FM!

Lecteur FM recherche sur Internet des podcasts de haute qualité que vous pourrez apprécier dès maintenant. C'est la meilleure application de podcast et fonctionne sur Android, iPhone et le Web. Inscrivez-vous pour synchroniser les abonnements sur tous les appareils.

 

Guide de référence rapide

Écoutez cette émission pendant que vous explorez
Lire